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Abstract
Background: Parental consanguinity is a risk factor for congenital heart disease (CHD) worldwide, suggesting that a
recessive inheritance model may contribute substantially to CHD. In Bangalore, India, uncle-niece and first cousin marriages
are common, presenting the opportunity for an international study involving consanguinity mapping of structural CHD. We
sought to explore the recessive model of CHD by conducting a genome-wide linkage analysis utilizing high-density
oligonucleotide microarrays and enrolling 83 CHD probands born to unaffected consanguineous parents.
Methodology/Principal Findings: In this linkage scan involving single nucleotide polymorphism (SNP) markers, the
threshold for genome-wide statistical significance was set at the standard log-of-odds (LOD) score threshold of 3.3,
corresponding to 1995:1 odds in favor of linkage. We identified a maximal single-point LOD score of 3.76 (5754:1 odds)
implicating linkage of CHD with the major allele (G) of rs1055061 on chromosome 14 in the HOMEZ gene, a ubiquitously
expressed transcription factor containing leucine zipper as well as zinc finger motifs. Re-sequencing of HOMEZ exons did not
reveal causative mutations in Indian probands. In addition, genotyping of the linked allele (G) in 325 U.S. CHD cases revealed
neither genotypic nor allele frequency differences in varied CHD cases compared to 605 non-CHD controls.
Conclusions/Significance: Despite the statistical power of the consanguinity mapping approach, no single gene of major
effect could be convincingly identified in a clinically heterogeneous sample of Indian CHD cases born to consanguineous
parents. However, we are unable to exclude the possibility that noncoding regions of HOMEZ may harbor recessive
mutations leading to CHD in the Indian population. Further research involving large multinational cohorts of patients with
specific subtypes of CHD is needed to attempt replication of the observed linkage peak on chromosome 14. In addition, we
anticipate that a targeted re-sequencing approach may complement linkage analysis in future studies of recessive mutation
detection in CHD.
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Introduction
Congenital heart disease (CHD) affects approximately one
percent of newborn infants [1,2], and accounts for one third of
deaths due to congenital malformations [3]. Worldwide, parental
consanguinity confers a two to three fold increase in risk for a
broad range of CHD phenotypes, as reported in Saudi Arabia
[4,5], Lebanon [6], and South India [7,8]. This implies that
recessive inheritance contributes to CHD occurrence. Consan-
guinity is already known to contribute to recessive Mendelian
syndromes in which CHD is a feature. For example, Ellis van
Creveld syndrome, due to homozygous mutations in EVC or EVC2
[9,10], presents with short stature, postaxial polydactyly, hidrotic
ectodermal dysplasia, and a broad range of cardiac defects, most
frequently septal defects or common atrium. The underlying
genetic etiology was identified in genetically isolated Amish
families [11]. Although syndromic CHD due to autosomal
recessive mutations has been conclusively demonstrated, few
genetic linkage investigations of nonsyndromic CHD have been
performed in relation to parental consanguinity. One notable
example identified PDA1 as a candidate locus for patent ductus
arteriosus in an Iranian population [12].
The consanguinity mapping approach has not yet been widely
applied to nonsyndromic CHD, in part because parental
consanguinity is uncommon in places where research efforts have
historically been most intense. However, interest is growing in the
statistical power of this approach for genetic investigations of other
complex phenotypes, such as autism, as demonstrated by the
Homozygosity Mapping Collaborative for Autism [13–17]. The
main advantage of consanguinity mapping is that a relatively small
number of pedigrees is required; as few as three families in which a
single affected child is born to first cousin parents can result in
1000:1 odds in favor of linkage, assuming no genetic heterogeneity
and tight linkage of a disease gene with fully informative DNA
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mapping,’’ because it assumes the identical-by-descent co-
transmission of a particular ancestral mutation by both parents
to an affected child. As such, this approach is only suitable for
consanguineous pedigrees.
CHD presents major public health challenges in India, due to the
large annual number of births in the Indian population and the
limited resources for specialized care of children with CHD [19].
Consanguineous marriages are traditional in South India, with
uncle-niece and cousin marriages being most common [20].
Studying a recessive model of CHD in this population is therefore
feasible. Thus, we ascertained CHD patients born to consanguin-
eous parents in India and referred to a center in Bangalore,
representing a broad range of structural heart malformations. We
hypothesized that consanguinity mapping would identify autosomal
recessivemutationsresponsibleforoneormoreCHDphenotypesin
this population. In order to accomplish this aim, we performed a
genome-wide linkage screen using dense oligonucleotide arrays in
CHD probands and their consanguineous parents.
Results
The phenotypic distributions of the cohorts are described in
Table 1. Initial screen with homozygosity mapping in the discovery
cohort did not reveal any regions in which all probands were
autozygous, as expected with a heterogeneous population. Two-
point linkage analysis resulted in two SNPs with LOD scores above
the standard threshold of 3.3 (Figure 1), indicating at least 1995:1
odds in favor of linkage [21]. The first SNP, rs1055061, lies in the
gene HOMEZ on chromosome 14 at 22,814,772. The LOD score
was 3.76 (5754:1 odds), and the optimal theta value was 0.05. The
genotype frequencies of the probands were GG=0.83, GA=0.13
and AA=0.04. The second SNP, rs12433225, yielded a LOD score
of 3.65 (4467:1 odds) and maps to chromosome 14 at 25,596,730,
more than250 kbawayfromanyknowngeneineitherdirection.As
a supplemental analysis, we also conducted a TDT test of
association using WASP, and obtained a significant p-value of
0.0495 for rs1055061 with the major allele (G) overtransmitted and
a non-significant p-value of 0.8185 for rs12433225.
Each of the linked SNPs was examined in the context of
autozygosity of the probands. SNP rs1055061 resided in a region
of autozygosity in 13 patients, while SNP rs12433225 localized to
a region of autozygosity in 14 patients. Analysis of 39 other SNPs
randomly selected from the Affymetrix platform resulted in a
mean of 6.6 probands (SE=0.4; SD=2.6) with autozygosity
surrounding the region of interest. Additionally, the minimum
region of autozygosity shared by the 13 patients surrounding
rs1055061 is Chr14:21,071,230–24,393,433, and the minimum
region of autozygosity shared by the 14 patients surrounding
rs12433225 is Chr14:24,952,386–25,774,000.
Table 1. Phenotypic distributions for affected patients in
both the discovery and replication cohorts.
Phenotype
Discovery
Cohort
Replication
Cohort
Conotruncal Lesions 28 (33.7%) 70 (21.6%)
Left Sided Obstructive Lesions 0 (0%) 2 (0.6%)
Right Sided Obstructive Lesions 5 (6%) 20 (6.2%)
Septal Defects 37 (44.6%) 123 (38%)
Single Ventricle Lesions 1 (1.2%) 83 (25.6%)
Valvular Defects 3 (3.6%) 18 (5.6%)
Complex Defects* 9 (10.8%) 8 (2.5%)
Total 83 325
*Complex defects refer to those lesions that had elements of multiple classes or
did not conform to the preceding classifications.
doi:10.1371/journal.pone.0010286.t001
Figure 1. Manhattan plot of results of linkage analysis. Dashed line indicates genome wide significant LOD score of 3.3. Significant SNPs,
rs1055061 and rs12433225 are represented.
doi:10.1371/journal.pone.0010286.g001
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On sequence analysis of the two coding exons, four previously
known SNPs [22] were identified in addition to rs1055061, namely
rs1057119, rs10131813, rs67447855, and rs71800228. In addi-
tion, three patients exhibited changes not previously described.
One proband had a heterozygous alteration in the 59 UTR region
(c.-116G.A), another displayed a Gly10Arg substitution in exon
1, and a third patient had a heterozygous deletion of T in the 39
UTR (c.+193delT).
The population in our linkage analysis was comprised of
children of consanguineous Indian parents. To determine if the
HOMEZ SNP rs1055061 was also associated with CHD in an
American population, we genotyped cases and controls from this
population to assess allele frequency differences using an ABI
TaqMan assay. Frequencies were 282 GG, 42 GA, and 1 AA in
325 patients with CHD and 548 GG, 57 GA and no AA in 605
control patients. The difference in the frequency of the GG
genotype in cases versus controls was not statistically significant by
Chi-squared analysis (P=0.074). Secondary analysis of an allele
frequency difference between cases and controls was not
statistically significant by Chi squared analysis (P=0.062).
Discussion
We have presented statistically significant linkage evidence for a
potential CHD susceptibility locus on chromosome 14 in a South
Indian population selected for consanguinity. However, the
linkage finding was not robust in a genetic association follow-up
study of CHD in the general United States population. Utilizing
the extensive genotyping information in oligonucleotide arrays,
linkage analysis revealed two markers with LOD scores above 3.3.
Because approximately 2.8 Mb separates these markers, a distance
far in excess of typical linkage disequilibrium values in the Indian
population [23], we conclude that these two SNPs are not
independently linked to a separate single causative mutation.
Of the two markers, only rs1055061 is intragenic, causing a
non-synonymous amino acid substitution. This SNP lies within
HOMEZ, a vertebrate specific homeobox gene with an interesting
structural organization. This transcription factor harbors three
atypical homeodomains, two leucine zipper-like motifs, and an
acidic domain. The protein is ubiquitously expressed in human
tissues, and has been further studied in a murine developmental
model [24]. Specific activity and pathway of this protein has not
yet been elucidated. Disease associated mutations in human
HOMEZ have not been described [25] and SNPs in this gene have
not been associated with any human phenotypes [22].
The rs1055061 SNP identified by linkage induces an amino acid
substitution from the polar, positively charged arginine to the
polar, but neutral glutamine. The allele with the higher population
frequency was overtransmitted in the TDT analysis, whereas one
might expect a rare recessive allele to confer susceptibility to an
uncommon phenotype such as CHD. Linkage analysis resulted in
a theta value of 0.05, indicating that a causative mutation most
likely lies within 50 kb of this SNP. Additionally, an increased
number of probands exhibited a region of autozygosity surround-
ing each of the linked SNPs, supporting our hypothesis of
autosomal recessive inheritance due to parental consanguinity.
We do acknowledge that the LOD score of 3.76 indicates a 1:5754
odds of this finding being due to chance alone, but argue that the
convergence of multiple methods of inquiry support rs1055061 as
a true finding.
We thus proceeded with sequence analysis of the coding regions
of HOMEZ in a subset of the Indian probands with the hypothesis
that a deleterious mutation in linkage disequilibrium with
rs1055061 would be discovered. We detected previously reported
SNPs and three novel sequence variations. None of the novel
variations were found to be homozygous, as would be expected for
causative mutations in offspring of a consanguineous relationship.
Thus, we were unable to identify any causative homozygous
mutations in the coding regions of HOMEZ.
We also studied the rs1055061 SNP in an American cohort of
patients affected with various types of CHD and compared them
to population controls. No significant difference was detected in
the genotype or allele distribution between cases and controls,
suggesting that our linkage finding in South Indians does not
extend to genetic association in an American population of mixed
European ancestry.
Although this study did not reveal definitive evidence of causal
mutations leading to autosomal recessive CHD, a number of
future directions and refinements are suggested. A limitation in the
application of consanguinity mapping to CHD is that the fraction
of this heterogeneous group of diseases attributable to recessive
inheritance and the approximate number of loci involved is not
known. Ascertaining consanguineous families with multiple
affected children (suggesting recessive inheritance) would theoret-
ically reduce genetic heterogeneity and increase power for linkage.
If only multiplex pedigrees are enrolled, the proportion of
probands with sporadic or autosomal dominant forms of CHD
will be minimized.
We did not restrict our analysis to specific CHD phenotypes
because it is impossible to select a priori which forms of CHD share
a common genetic etiology. This may have resulted in diffusion of
the linkage signal because of both clinical and genetic heteroge-
neity. Enriching the study population for predefined, specific
phenotypic classes would likely decrease genetic heterogeneity in
the study population.
Recent work in massively parallel whole exomic [26] as well as
whole genomic [27,28] re-sequencing suggests complimentary or
alternative approaches to supplement current methods in
consanguinity mapping. As technologies advance, identification
of linked regions followed by targeted capture and deep
resequencing of these regions with the aim of detecting locus-
specific recessive mutations in multiple affected individuals may
further enhance the power of consanguinity mapping. The
increased power of this approach may allow for the suggested
modifications of utilizing more informative and complex families
while concentrating on specific forms of CHD in order to decrease
genetic heterogeneity.
Materials and Methods
Ethics Statement
Written informed consent was provided by the parents of all
children assenting to participate in the study, using consent
documents approved by the ethics board of Narayana Hrudaya-
laya Heart Hospital. Dr. Sunita Maheshwari, Principal Investiga-
tor at Narayana Hrudayalaya Heart Hospital, and Dr. Amit Misri,
co-investigator, obtained consent from participating families.
Genotyping was performed on de-identified samples without
knowledge of any personal identifiers under IRB approval from
Yale University, Washington University in St. Louis, and
Vanderbilt University.
Population
We enrolled children affected with congenital heart disease and
born to consanguineous parents in order to identify candidate regions
for CHD by linkage analysis. The families were ascertained in a
cardiology clinicat Narayana Hrudayalaya in Bangalore, India, from
Consanguinity Mapping in CHD
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structural congenital heart disease and parental consanguinity.
Exclusion criteria were isolated conduction system defect, cardiomy-
opathy, or extracardiac syndromic features. The patients had an
echocardiogram performed in the clinic and interpreted by pediatric
cardiologists. In all, 83 probands were recruited from 81 families.
Probands were not known to be related to each other with the
exception of one family that enrolled three affected siblings. Both
parents were recruited in 71/81 families, and one parent in 10/81
families. The phenotypic distribution of the probands’ cardiac lesions
is described in Table 1, and the median age was 5.3 years
(interquartile range 1.3–11.0 years). The parental relationships were
uncle-niece for 42/81 families and first cousins for 39/81 families.
Replication Cohort
A replication cohort of 325 probands affected with congenital
heart disease was ascertained at Vanderbilt University Medical
Center via therapeutic clinical trials of oral [29] or intravenous
citrulline [30] for prevention of pulmonary hypertension. The
CHD cases were compared with 605 population-based controls
without CHD, the characteristics of whom were described
previously [31]. Neither probands nor controls were known to
be the product of a consanguineous relationship and nearly all
were White, with a small number of cases (n=39) and controls
(n=15) being of mixed Hispanic ancestry. Because the minor
allele frequency of rs1055061 varies by population (the A allele has
highest frequency in Africans and lowest in Whites), we restricted
our analysis to White and Hispanics to account for this known
population variation.
Genomic DNA for probands 1–26; 39–50 and relatives was
isolated from blood spots on Whatman filter paper using GenSolve
blood spot DNA recovery kit according to the manufacturer’s
protocol (Whatman Inc., Florham Park, NJ). DNA from probands
27–38 was isolated from peripheral blood samples using Gentra
PureGene Blood Kit (Qiagen, Valencia, CA). For probands 51–83
and relatives, saliva was collected with Oragene kits, and DNA was
extracted per manufacturer’s protocol (DNA Genotek Inc.,
Kanata, Ontario, Canada). We performed genome wide scans
utilizing Affymetrix SNP 5 microarrays for probands 1–30 and
relatives with genotyping reactions performed at Precision
Biomarker Resources (Evanston, IL). Probands 39–83 and
relatives were genotyped on Affymetrix SNP 6.0 microarrays,
and genotyping reactions were performed according to the
manufacturer’s instructions (Affymetrix, Santa Clara, CA). Geno-
types were generated using the BRLMM-P for Affymetrix SNP 5
arrays and the Birdseed V-2 algorithm for Affymetrix SNP 6.0
arrays as released in Genotyping console v3.0.1 (Affymetrix, Santa
Clara, CA). The SNP 5 arrays had an average QC call rate of
94.5% with SD of 4.8%. The SNP 6 arrays had an average QC
call rate of 91.2% with SD of 5.6%. The genotype data was
exported as .chp files and further analyzed with Merlin,v1.1.2
[32]. Genotypes on the sex chromosomes were excluded from the
analysis, as these would not fit the hypothesized recessive model.
Genotypes for SNPs present on both platforms were selected for
analysis (n=427,829). Quality control filters were run sequentially
using the Whole-genome Association Study Pipeline (WASP) [33].
SNPs with genotype efficiency ,95% (n=268,653), a minor allele
frequency ,10% (n=68,415), or Hardy Weinberg equilibrium
with p,0.0001 (n=867) were excluded. Because of the consan-
guineous nature of our population, we performed linkage analysis
assuming a recessive mode of inheritance. Assuming a disease
frequency of 0.01 and penetrance of 0.5, two-point analysis was
conducted on the 89,894 SNPs that passed filtering criteria using
Merlin. Since the Transmission Disequilibrium Test (TDT) is
robust for linkage in the presence of inbred populations [34], TDT
was performed for the SNPs with LOD .3.3 utilizing trios
informative for each locus. All SNP citations and positions are
given in reference to dbSNP build 129 [22] and the UCSC human
genome browser [35] with the March 2006 assembly.
Assessment of regions of autozygosity were conducted in Partek
software, V6.4 Copyright 2009 (Partek Inc., St. Louis, MO) with
the algorithms for loss of heterozygosity (LOH). Unpaired analysis
parameters included max probability 0.99, genomic decay 0,
genotype error 0.02, and default frequency 0.3. All genotype calls
from the probands were used to generate array specific baselines.
Random markers were selected from the Affymetrix SNP5 &
SNP6 platforms using a random number generator. Each result
from the LOH analysis overlapping the genomic location of
interest was visually inspected to determine true autozygosity.
We carried out a mutation screening of HOMEZ with
bidirectional sequencing in a subset of Indian probands (n=54).
Four primer sets covering the coding exons and their flanking
regions were designed with Primer3 (http://frodo.wi.mit.edu/cgi-
bin/primer3/primer3_www.cgi). Fragment amplification was
performed under standard PCR conditions. In brief, 50 ng of
DNA was used in the reaction; PCR program started with 94uC
for 5 min, 35 cycles of 94uC, 57uC and 72uC, a final extension
cycle of 72uC for 6 minutes and stored at 4uC. PCR products were
purified using Exo-SAP (Fermentas) and sequenced with the ABI
3730xl DNA Analyzer at the DNA Sequencing Facility,
Vanderbilt University.
For the replication cohort, a proprietary TaqMan genotyping
assay for rs1055061 was obtained from Applied Biosystems (Assay
ID: C___2484687_10). After lyophilizing 10 ng genomic DNA
per sample, the genotyping assay and TaqMan Universal PCR
Master Mix (Applied Biosystems 4371355) were then prepared
and run as per manufacturer’s protocol. Applied Biosystems SDSH
2.3 was used to analyze the results of the genotyping assay.
Genotypes were assigned without knowledge of the affected status
of the samples.
Author Contributions
Conceived and designed the experiments: TLM AM SM TMM.
Performed the experiments: TLM GO RDF TMM. Analyzed the data:
TLM JB GO RDF DS TMM. Contributed reagents/materials/analysis
tools: TLM TMM. Wrote the paper: TLM TMM. Collected and
phenotyped subjects: AM SM. Critically reviewed paper: AM JB DS
SM.
References
1. Hoffman JI, Kaplan S, Liberthson RR (2004) Prevalence of congenital heart
disease. Am Heart J 147: 425–439.
2. Hoffman JI, Kaplan S (2002) The incidence of congenital heart disease. J Am
Coll Cardiol 39: 1890–1900.
3. Petrini J, Damus K, Russell R, Poschman K, Davidoff MJ, et al. (2002)
Contribution of birth defects to infant mortality in the United States. Teratology
66 Suppl 1: S3–6.
4. Becker SM, Al Halees Z, Molina C, Paterson RM (2001) Consanguinity and
congenital heart disease in Saudi Arabia. Am J Med Genet 99: 8–13.
5. Becker S, Al Halees Z (1999) First-cousin matings and congenital heart disease in
Saudi Arabia. Community Genet 2: 69–73.
6. Nabulsi MM, Tamim H, Sabbagh M, Obeid MY, Yunis KA, et al. (2003)
Parental consanguinity and congenital heart malformations in a developing
country. Am J Med Genet A 116A: 342–347.
7. Ramegowda S, Ramachandra NB (2006) Parental consanguinity increases
congenital heart diseases in South India. Ann Hum Biol 33: 519–528.
8. Gnanalingham MG, Gnanalingham KK, Singh A (1999) Congenital heart
disease and parental consanguinity in South India. Acta Paediatr 88: 473–474.
Consanguinity Mapping in CHD
PLoS ONE | www.plosone.org 4 April 2010 | Volume 5 | Issue 4 | e102869. Ruiz-Perez VL, Ide SE, Strom TM, Lorenz B, Wilson D, et al. (2000) Mutations
in a new gene in Ellis-van Creveld syndrome and Weyers acrodental dysostosis.
Nat Genet 24: 283–286.
10. Galdzicka M, Patnala S, Hirshman MG, Cai JF, Nitowsky H, et al. (2002) A new
gene, EVC2, is mutated in Ellis-van Creveld syndrome. Mol Genet Metab 77:
291–295.
11. Polymeropoulos MH, Ide SE, Wright M, Goodship J, Weissenbach J, et al.
(1996) The gene for the Ellis-van Creveld syndrome is located on chromosome
4p16. Genomics 35: 1–5.
12. Mani A, Meraji SM, Houshyar R, Radhakrishnan J, Ahangar M, et al. (2002)
Finding genetic contributions to sporadic disease: a recessive locus at 12q24
commonly contributes to patent ductus arteriosus. Proc Natl Acad Sci U S A 99:
15054–15059.
13. Hu-Lince D, Craig DW, Huentelman MJ, Stephan DA (2005) The Autism
Genome Project: goals and strategies. Am J Pharmacogenomics 5: 233–246.
14. Hutcheson HB, Bradford Y, Folstein SE, Gardiner MB, Santangelo SL, et al.
(2003) Defining the autism minimum candidate gene region on chromosome 7.
Am J Med Genet B Neuropsychiatr Genet 117B: 90–96.
15. Collaborative Linkage Study of Autism (2001) An autosomal genomic screen for
autism. Am J Med Genet 105: 609–615.
16. Collaborative Linkage Study of Autism (2001) Incorporating language
phenotypes strengthens evidence of linkage to autism. Am J Med Genet 105:
539–547.
17. Barrett S, Beck JC, Bernier R, Bisson E, Braun TA, et al. (1999) An autosomal
genomic screen for autism. Collaborative linkage study of autism. Am J Med
Genet 88: 609–615.
18. Lander ES, Botstein D (1987) Homozygosity mapping: a way to map human
recessive traits with the DNA of inbred children. Science 236: 1567–1570.
19. Saxena A (2005) Congenital heart disease in India: a status report.
Indian J Pediatr 72: 595–598.
20. Bittles AH (2002) The impact of consanguinity on the Indian population. Indian
Journal of Human Genetics 8: 45–51.
21. Lander E, Kruglyak L (1995) Genetic dissection of complex traits: guidelines for
interpreting and reporting linkage results. Nat Genet 11: 241–247.
22. Database of Single Nucleotide Polymorphisms (dbSNP). dbSNP Build ID: 129
ed. Bethesda (MD): National Center for Biotechnology Information, National
Library of Medicine).
23. Pemberton TJ, Jakobsson M, Conrad DF, Coop G, Wall JD, et al. (2008) Using
population mixtures to optimize the utility of genomic databases: linkage
disequilibrium and association study design in India. Ann Hum Genet 72:
535–546.
24. Bayarsaihan D, Enkhmandakh B, Makeyev A, Greally JM, Leckman JF, et al.
(2003) Homez, a homeobox leucine zipper gene specific to the vertebrate
lineage. Proceedings of the National Academy of Sciences of the United States of
America 100: 10358–10363.
25. McKusick-Nathans Institute of Genetic Medicine (2009) Online Mendelian
Inheritance in Man, OMIM (TM). Johns Hopkins University (Baltimore, MD),
National Center for Biotechnology Information, National Library of Medicine
(Bethesda, MD).
26. Ng SB, Turner EH, Robertson PD, Flygare SD, Bigham AW, et al. (2009)
Targeted capture and massively parallel sequencing of 12 human exomes.
Nature 461: 272–276.
27. Lifton RP (2010) Individual Genomes on the Horizon. N Engl J Med, 2010/03/
10 ed.
28. Lupski JR, Reid JG, Gonzaga-Jauregui C, Rio Deiros D, Chen DC, et al. (2010)
Whole-Genome Sequencing in a Patient with Charcot-Marie-Tooth Neurop-
athy. N Engl J Med, 2010/03/10 ed.
29. Smith HA, Canter JA, Christian KG, Drinkwater DC, Scholl FG, et al. (2006)
Nitric oxide precursors and congenital heart surgery: a randomized controlled
trial of oral citrulline. J Thorac Cardiovasc Surg 132: 58–65.
30. Barr FE, Tirona RG, Taylor MB, Rice G, Arnold J, et al. (2007)
Pharmacokinetics and safety of intravenously administered citrulline in children
undergoing congenital heart surgery: potential therapy for postoperative
pulmonary hypertension. J Thorac Cardiovasc Surg 134: 319–326.
31. Morgan TM, Krumholz HM, Lifton RP, Spertus JA (2007) Nonvalidation of
reported genetic risk factors for acute coronary syndrome in a large-scale
replication study. JAMA 297: 1551–1561.
32. Abecasis GR, Cherny SS, Cookson WO, Cardon LR (2002) Merlin–rapid
analysis of dense genetic maps using sparse gene flow trees. Nat Genet 30:
97–101.
33. Sexton DP, McCauley JL, Giles JT, Bush WS, Bradford Y, et al. (2007) The
Whole-genome Association Study Pipeline (WASP): A Comprehensive Tool for
Large-Scale Association Studies. American Society of Human Genetics. San
Diego, California.
34. Genin E, Todorov AA, Clerget-Darpoux F (2002) Properties of the transmission-
disequilibrium test in the presence of inbreeding. Genet Epidemiol 22: 116–127.
35. Kuhn RM, Karolchik D, Zweig AS, Wang T, Smith KE, et al. (2009) The
UCSC Genome Browser Database: update 2009. Nucleic Acids Res 37:
D755–761.
Consanguinity Mapping in CHD
PLoS ONE | www.plosone.org 5 April 2010 | Volume 5 | Issue 4 | e10286